JPMorgan Chase & Co. has filed a major holdings notification revealing a combined position of 8.015325% in Bodycote plc (BOY), the UK-listed specialist thermal processing and heat treatment services group. The threshold was crossed on 13 November 2026, with the issuer notified on 17 November 2026. The position is held through a combination of direct shares and an extensive portfolio of cash-settled equity swaps, representing a material institutional holding in the FTSE-listed industrial company. Investors may be watching the disclosure closely given the size and structure of the position.

Key Points

  • Bodycote plc (BOY) — UK-listed thermal processing and heat treatment services company
  • JPMorgan Chase & Co. has disclosed a total voting rights position of 8.015325% in Bodycote plc
  • Threshold crossed on 13 November 2026; total voting rights held equal 13,641,121 shares
  • Investors should watch for any further changes to JPMorgan's position in subsequent TR-1 filings

JPMorgan's Combined 8.02% Position in Bodycote Breaks Down Across Shares and Swaps

According to the TR-1 notification, JPMorgan Chase & Co. holds 0.660713% of Bodycote's voting rights through direct shares, amounting to 1,124,454 shares held via J.P. Morgan Securities PLC. The remaining 7.354612% is attributable to financial instruments with similar economic effect — specifically a portfolio of 19 cash-settled equity swaps held through multiple controlled subsidiaries. Together, these components bring the total position to 8.015325%, representing 13,641,121 voting rights in Bodycote plc as at 13 November 2026.

Cash-Settled Equity Swaps Account for the Majority of JPMorgan's Bodycote Exposure

The notification details 19 individual cash-settled equity swap positions, the largest of which carries 2,729,025 voting rights, equivalent to 1.603536% of Bodycote's share capital, expiring on 30 April 2027. Other significant swap positions include 2,600,756 voting rights expiring 29 July 2027 and 2,367,294 voting rights expiring 16 June 2027. Because these instruments are cash-settled rather than physically settled, they do not confer an automatic right to acquire the underlying Bodycote shares, though they do provide economic exposure to movements in Bodycote's share price.

How JPMorgan's Current Position Compares With Its Previous Bodycote Notification

The filing notes a previous notification position of 8.023078% in total, comprised of 1.502160% in direct voting rights and 6.520918% through financial instruments. The resulting situation as at 13 November 2026 shows the direct share component has decreased from 1.502160% to 0.660713%, while the financial instruments component has increased from 6.520918% to 7.354612%. The overall combined holding has marginally declined by approximately 0.008 percentage points, reflecting a rebalancing between physical shares and derivative exposure rather than a significant change in aggregate economic interest.

Bodycote plc and the Regulatory Context of the Major Holdings Disclosure

Bodycote plc, headquartered in the UK and identified by ISIN GB00B3FLWH99, provides specialist thermal processing services to manufacturers across aerospace, automotive, and industrial sectors. The TR-1 form is a standard regulatory disclosure required under the Financial Conduct Authority's Disclosure and Transparency Rules when an investor's holding crosses certain thresholds. The notification was completed in London on 17 November 2026, with JPMorgan Chase & Co. acting as the ultimate controlling entity across a chain of wholly owned subsidiaries including J.P. Morgan Securities PLC, J.P. Morgan SE, and J.P. Morgan Markets Limited.